Main menu
Edison Group
  • Home
  • Equities

    Equities

    View All Equities

    Equities by Sector

    IRLAB Therapeutics

    MCap

    SEK653m

    Last close

    SEK14.10

    ▲ 1.50 (11.90%)

    VolitionRx

    MCap

    USD51m

    Last close

    USD0.60

    ▲ 0.05 (9.82%)

    Portobello SpA

    MCap

    EUR12m

    Last close

    EUR2.38

    ▲ 0.20 (9.17%)

  • Sectors

    Sectors

  • Thematics

    Thematics

    View All Thematics

    Latest

  • Audiovisual

    Audiovisual

    View All Audiovisual

    Latest

PBKM – EKF interview

PBKM – EKF interview

Polski Bank Komórek Macierzystych — 1 video in collection

More on this equity

Polski Bank Komorek Macierzystych (PBKM) operates a group of stem cell banks under the FamiCord Group brand. It also develops stem cell therapy for the treatment of a number of diseases. In this interview, Jakub Baran (President of the Management Board) provides the background to PBKM’s product and expected market developments, including the impact of COVID-19 on its distribution channels. He also discusses the company’s geographic expansion and current focus. He explains how PBKM is positioned for further growth. Finally, he sheds some light on develpments related to the company’s CAR-T project.

< Previous
Next >

You may also be interested in these:

Healthcare

Making the ordinary, extraordinary: Next generation T cell receptors for precision immunotherapies

Healthcare

Volition webinar: Nu.Q NETs data insights

Subscribe to Edison

Get access to the very latest content matched to your personal investment style.

Sign up for free